Trial Profile
A phase Ib clinical trial to evaluate SUVN 502
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 Jul 2014
Price :
$35
*
At a glance
- Drugs Masupirdine (Primary)
- Indications CNS disorders
- Focus Adverse reactions
- 15 Jul 2014 New trial record